[1] |
LEI Yajie , GAO Yi , WANG Zhijie , CHENG Xi , YANG Yufei , ZHOU Hongyu , CHEN Lihua , CHEN Yixin , LI Haoran , LI Ziting , WU Xiaohua .
Potential role of lymphadenectomy in patients with ovarian cancer (ⅠC-ⅡA): a retrospective trial
[J]. China Oncology, 2021, 31(8): 740-745.
|
[2] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
[3] |
CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin.
Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
[J]. China Oncology, 2021, 31(4): 330-334.
|
[4] |
LIU Yixuan , WEN Zexuan , GUO Lin , LU Renquan .
The function of TTK1 in platinum-resistant ovarian cancer
[J]. China Oncology, 2021, 31(3): 182-191.
|
[5] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[6] |
HE Hesheng , YANG Yuqiong , LIU Yinhua , JIN Xiaoke , XU Youhai , YAO Junping , LIU Shanhao , YAN Jiawei , HUANG Dongping .
Characteristic analysis of peripheral T-cell lymphoma associated with autoimmune hemolytic anemia
[J]. China Oncology, 2021, 31(2): 121-125.
|
[7] |
LI Lei , WANG Zhi , YOU Chunyuan .
The relapse of primary cardiac high-grade B-cell lymphoma after remission: a case report
[J]. China Oncology, 2021, 31(2): 156-160.
|
[8] |
LI Panpan, ZHANG Zhuo.
Analysis of prognostic factors in 42 cases of primary central nervous system lymphoma
[J]. China Oncology, 2021, 31(12): 1194-1201.
|
[9] |
YU Yi, CONG Qing, XU Congjian, JIANG Wei.
The effect of PAFR on cisplatin sensitivity in ovarian cancer cells and its mechanism
[J]. China Oncology, 2021, 31(11): 1063-1071.
|
[10] |
LIU Jiawei, LI Dan, ZHAI Qing.
Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer
[J]. China Oncology, 2021, 31(1): 52-62.
|
[11] |
WANG Zhihen , MAO Peimin , JIANG Hongyuan , FAN Lingling .
Assessment of the diagnostic value of CPH-I, CA12-5 and HE4 for cancer prediction in women with ovarian masses with papillary projections diagnosed by ultrasound
[J]. China Oncology, 2020, 30(8): 599-604.
|
[12] |
YAN Fang, YING Mingzhen, CHEN Longpei, FU Qiang.
Clinical observation of albumin-bound paclitaxel plus nedaplatin as first-line treatment in advanced esophageal squamous cell carcinoma patients
[J]. China Oncology, 2020, 30(8): 632-635.
|
[13] |
ZHANG Xiaomeng , MA Ningyi , ZHU Hongcheng , AI Dashan , REN Zhigang .
Efficacy and prognostic factors of adjuvant radiotherapy combined with chemotherapy in patients with pancreatic cancer
[J]. China Oncology, 2020, 30(7): 519-524.
|
[14] |
ZHAO Haiyun, WU Xiaohua.
Research progress of immunotherapy in ovarian cancer
[J]. China Oncology, 2020, 30(7): 538-545.
|
[15] |
WANG Xiaoqin, FU Xinlei, MA Ruyue, YANG Lina, CHEN Yaping, ZHANG Liwen.
Sema3A regulates metastasis through epithelial-mesenchymal transition/matrix metalloproteinase-2 in epithelial ovarian cancer
[J]. China Oncology, 2020, 30(6): 428-434.
|